TP53 and neoplasm: Of the 69 HPV+ HNSCC, one tumor carried a TP53 substitution (missense, in this case)—a tumor that was also classified as HPV+ in the comprehensive genomic characterization of HNSCC conducted by TCGA (TCGA-CR-7638) [21].